“We’re opening a representative office in Chisinau and in the second half another one in Kiev, while in Vietnam, where have an office we will finish hiring and have already introduced 30 products on the market. Next month we’ll be going to the US for two new distribution partners,” Ioan Nani, CEO of Antibiotice Iasi, told ZF.
The representative of the pharmaceutical company says Antibiotice will continue to develop on international markets. This year’s target is to have exports generate 40% of the revenue compared with 32% in 2017.
Antibiotice Iasi posted 336 million lei (EUR72 million) revenue and RON33 million profit last year, according to the preliminary data in its filing with the Bucharest Stock Exchange. (EUR1=RON4.6552)
(English version by Loredana Fratila-Cristescu)